Evaluation of AP-002 in Patients With Solid Tumors
NCT04143789
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
UNKNOWN
Status
61
Enrollment
INDUSTRY
Sponsor class
Conditions
Solid Tumor
Interventions
DRUG:
AP-002
Sponsor
Altum Pharmaceuticals INC